A Hong Kong University of Science and Technology (HKUST) research team has developed a catalytic enantioselective type II [5 ...

A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...

Kura Oncology won FDA priority review for its drug the day before announcing new data at ASCO 2025 showing remission in about ...

The Federal Circuit recently considered the scope of a permanent injunction that prohibited a drug manufacturer from ...

Tenpoint Therapeutics announced that the new drug application (NDA) for its presbyopia candidate, brimochol PF, has been ...

XP 8121 is a combination drug meant to better control hypothyroidism, in part by moving its common therapy, levothyroxine, ...

The development of innovative pharmaceuticals targeting refractory mental health conditions has stagnated for decades. In recent years, ...

Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about ...

Luca Shaefer, the founder of Overdose Awareness and Response St. John's, says she wants provide support to a marginalized ...